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INTRODUCTION
Cervical cancer is the second most cancer of women in the world. World Health Organization (WHO) estimates that in Indonesia there are 13.762 Indonesian women who are diagnosed with cervical cancer and 7.493 die from this disease. 1 The etilogy of cervical cancer is Human Pappilomavirus (HPV) infection. There are two groups of HPV types, the high-risk HPVs, which are associated with the development of cervical cancer, which are HPV types 16, 18, 26, 31, 33, 35, 39, 45 , 51, 52, 53, 56, 58, 59, 61, 73 and 81, and low-risk HPVs which are associated with the incidence of benign warts in the oral and urogenital epithelium in adults and children, and is rarely found in malignant tumors ie types 6, 11, 40, 42, 43, 44, 54, 61, 72 and 81. 3 Cervical cancer is preventable because they have fairly long period of precancer. The pathological process from HPV infection to cancer takes about 3 to 20 years. 4 HPV infection causes precancerous lesion starting from mild dysplasia or interepithelial cervical cervix (CIN) 1, moderate dysplasia (also called CIN 2) and severe dysplasia (also called CIN 3), laterly causes invasive malignancy. The precancerous lesions period is a period of silence, in which the disorder does not cause symptoms in patients, and therefore, regular examination should be done to detect precancerous lesions as early as possible. The detection of high-risk HPV type can be used as an additional biomarkers for routine cytology examination in precancer lesion screening, management of abnormal border line cytology (ASCUS), follow-up in women who have received treatment for HSIL, and to categorize women based on precancerous lesions and cancer risk factors. 5, 6 HPV genotypes examination during precancerous lesions is needed to predict the outcome of disease in patients.
Considering those facts, the purpose of this study to determine the genotype of HPV in the cervical tissue of patients with CIN 1, CIN 2 and CIN 3 and hopefuly can be used to predict the disease outcome in patients.
MATERIALS AND METHODS
This is an observational descriptive study with cross sectional approach to explore the types of HPV infecting patients with CIN 1, CIN 2, CIN 3, using the paraffin block preparations in Dr Soetomo Hospital. The population of this study are patients with CIN 1, CIN 2, CIN 3 who were performed histopathology examination using HE staining in the Pathology Department Installation of Medical Faculty, Airlangga University, Dr Soetomo Hospital during January 1 st to December 31 st 2013. The samples were taken from cervical biopsies procedure done towards patients with CIN 1, CIN 2 and CIN 3, and.then processed to be paraffin blocks.
The inclusion criteria of this study were 1) histopathological examination should be performed at the Anatomical Pathology Installation of Dr Soetomo Hospital, 2) microscopic appearances are in accordance with the CIN 1, CIN 2 and CIN 3 criteria, 3) tissues in paraffin blocks are still representative for the research' purposes. The exclusion criterias are not sufficient samples and damaged tissue in the paraffin blocks.
Paraffin block numbers are firstly recorded, then the paraffin blocks and slides which were stained by Hematoxillin eosin (HE) were collected. The HE slides were used for histopathological examination to determine whether or not the microscopic appearances match the criteria in the study. Paraffin blocks which are still representative are laterly used as randomy taken samples using simple random sampling technique.
HPV DNA was extracted from paraffin blocks using Nucleospin Tissue (Macherey Nagel) reagents. The paraffin blocks were cut using microtome, resulting 5 pieces of slides, each was 5µm thick, then tube ependrof was inserted for deparafination process using xylol. DNA extraction was done according to the manual instructions for reagents usage. C for 5 minutes in 1 cycle. HPV genotyping is done using HPV-Type Express Ampliquality (AB analitica) with reverse line blot technique. The results are in the form of ribbons on a blot membrane which is in accordance with the type of HPV. The collected data were calculated and analyzed using percentages and were presented in the form of images and tables.
RESULTS AND DISCUSSION
The sample used in the study consisted of 28 paraffin blocks of cervical tissue derived from patients with CIN 1 (10 blocks), CIN 2 (10 blocks) and CIN 3 (8 blocks). The patients aged between 26-74 years old (standard deviation of 10:12) ( Table 1) . Cervical Intraepithelial Neoplasia (CIN) 1 is characterized by the presence of mild dysplasia in one third layer of squamous epithelial cells whose nucleus are about to swell and more hyperchromatic, or the presence of cells infected with HPV with slightly enlarged nucleus, more hyperchromatic, and irregular nucleus edge. The core is surroundded by perinuclear hallo (koilositosis) (Figure 1 ). CIN 2 is characterized by moderate dysplasia in two-third layer of squamous epithelial cell whose nucleus are about to swell, and more hyperchromatic (Figure 2 ). CIN 3 is characterized by severe dysplasia in the whole layers of squamous epithelial cell whose nucleus are enlarged, hyperchromatic, with thinner cytoplasm (Figure 3 ) . 14 HPV types that are identified in normal cervix and LSIL in Japan are HPV-11, -16, -18, -30, -31, -33, -35, -39, -42, -44, -45, -51, -52, -53, -54, -55, -56, -58, -59, -61 16 HPV testing in patients with CIN2 is helpful to diagnose the border line cases or cases of normal cytology, as well as to follow up patients with CIN 2. HPV testing in CIN 3 are needed to monitor the cervix of patients with CIN 3 who are treated surgically. Cytological examination during the treatment follow-up, is less sensitive, since the smear results are difficult to evaluate, while 5-10% of patients usually experience relapse. HPV testing is useful to follow up the those cases and is more sensitive. Negative results imply that there is perfect healing so that the woman can follow a routine screening . 5 Detection of HPV types are generally useful to predict the cervix of infected women. Based on the clinicopathology grading consensus, HPV testing can be used to justify ASCUS clinically. Determining HPV type and detection of multiple HPV in clinical samples can be used as an secondary marker for cervix cell abnormalities. 15 High-risk types of HPV infection can trigger the development of cervical cancer, while low-risk HPV can lead to genital warts cases.
HPV genotypes found in LSIL cases of this research are HPV 16 and 18. Eventhough in LSIL patients there is a possibility of complete healing and disappearance of the virus because of increased immunity, it is still necessary to monitor the health of the cervix for the next 6 months. LSIL can either evolve to HSIL or recover completely. The results of this study shows that in LSIL, the HPV infecting cervix are the high risk types. Therefore, it is possible to progress towards HSIL. HPV genotypes of HSIL cases in this study are single infections such as HPV 16, HPV 52, HPV 67, and combined infections such as HPV 16/67 and 52/67. HPV types 16, 52, and 67 are high-risk types. Combined infection of two high-risk types of HPV can accelerate the development towards invasive cervical carcinoma. Patients should get conication procedure with loop electrical excition procedure (LEEP) to recover. HPV testing still need to be done in patients with HSIL after the procedure to monitor the healing progress.
High-risk HPV types are the mostly found types in HSIL and almost all cervical cancers, while in LSIL, obly 60% were infected with high risk HPV types. Single or combined, high-risk HPV types infections are more often found in HSIL and SCC compared with the LSIL and normal cervix. 15 High-risk HPV infection infects longer than the low-risk HPV types. The immune response in the cervix can easily beat the lowrisk HPV types, where high-risk HPV types are resistant to immunity and infect longer. High-risk types of HPV infection appears to be related to persistent infection and were able to develop into HSIL and SCC. 15 This study found that the combined HPV infection is a factor in persistent HPV infection in young women with a normal cervix. Persistent HPV infection indicates the degree of cervical dysplasia development. Multiple HPV infection appears to be related to cervical neoplasia development. Multiple infections produce conditions that alter the immune protection to be a persistent infection. 15 There are several combined infections in clinical samples. The combined infection seems to be typical in women with cervical abnormalities and was significantly associated with the risk of LSIL, HSIL and SCC. The combined infection is more common in LSIL compared to malignant lesions (HSIL and SCC). 15 The results of this study indicate that the most dominant types of HPV infecting the patients with cervical abnormalities in this study is HPV 16 (86%), HPV 67 (11%), HPV 52 (8%), HPV 18 (4%). Most types of HPV that cause cervical cancer are HPV 16 and 18. The detection of high risk HPV types can be used as an additional biomarker for routine cytologic examinations in screening for precancerous lesions, management of abnormal borderline cytology result (ASCUS) and follow-up in women who has gone through the treatments for HSIL and to categorize women based on precancerous lesions and cancer risk factors (Meijer CJ, et al, 2006 , Youens KE, et al, 2011 . These HPV types are associated with protection against cervical cancer. Vaccines which are available today are HPV 16/18 bivalent and quadrivalent HPV 16/18 and 6/11 vaccine. HPV 16/18 vaccination can provide protection against cervical cancer caused by HPV 16 and 18 infection. The second-generation of HPV vaccines, with the addition of HPV types, is expected to provide higher protection against progression toward malignancy.
CONCLUSION
The most dominant HPV genotypes infecting patients with cervical precancerous lesions in this research are HPV 16, HPV 67, HPV 52 and HPV 18, and therefore, HPV types 52 and 67 should be considered to be a second-generation HPV vaccine for protection against cervical cancer incidence in Indonesia.
